Taking people in Németország1. fázis
A Phase 1b, Double-Blind Study to Investigate Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of Single Dose of ATI-052 in Participants with Mild to Moderate Asthma
Key facts
- Where
- Berlin és Luebeck, NémetországSee the 2 sites
- Phase
- 1. fázis
Where in Németország
- Parexel International GmbHBerlin, NémetországTaking people
- Velocity Clinical Research Germany GmbHLuebeck, NémetországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aclaris Therapeutics Inc.
- Trial code
- EU 2025-524987-39-00
- Record updated
- 2026. november 5.